Im Cannabis Corp. · NASDAQ:IMCC
Im Cannabis — Investor Presentation (January 2022)
26 slides from Im Cannabis's investor presentation, January 2022
Slide 1: An International Cannabis Company
AN INTERNATIONAL CANNABIS COMPANY PURVEYOR OF PREMIUM CANNABIS GLOBALLY - IMC CANNABIS CORP NASDAQ: IMCC CSE: IMCC JANUARY 2022
Slide 2: General
GENERAL The information contained herein, and any other materials provided by IM Cannabis Corp.(“IMC” or the “Company”), are intended solely for imposed on a more strict basis, including restrictions on movement and businesses; the extent to which COVID-19 impacts the global discussion purposes and
Slide 3: United States Securities Laws; Non-IFRS Financial Measures
UNITED STATES SECURITIES LAWS NON-IFRS FINANCIAL MEASURES This investor presentation is not a prospectus or an offering memorandum pursuant to applicable US securities laws. The securities of IMC This presentation makes reference to certain non-IFRS financial measures including "Gross Margin", “EBIT
Slide 4: IMC: A Global Platform
IMC: A GLOBAL STRATEGIC REACH: Operating in the 3 largest federally legal markets, PLATFORM Israel, Germany, and Canada STRONG FINANCIAL POSITION 30/9/2021 THE IMC VISION $34mm $8mm $11mm PURSING AN INTEGRATED GLOBAL EXPANSION AND Revenue TTM Gross Profit TTM1 Total Cash, $11mm net cash GROWTH STRAT
Slide 5: IM Cannabis at a Glance
IM CANNABIS AT A GLANCE IMC IS THE ONLY MULTI - COUNTRY OPERATOR WITH OPERATIONS IN CANADA, GERMANY& ISRAEL CANADA GERMANY ISRAEL • Premium, indoor-grown capacity of ~7,000 kgs per year • EU-GMP certified licensed • Leading medical brand with 10+ year • Facilities in Ontario, Quebec and Nova Scotia
Slide 6: IMC Timeline
IMC TIMELINE Where We How We Where We Are Today Got Here Are Heading • The only cannabis company with multi- • Over 11 years growing and selling cannabis • Leveraging our global supply chain to country operations in the three largest in Israel ensure consistent supply of premium legal cannabis marke
Slide 7: Executing on Our Vision: A Global Operator Controlling the Entire Value Chain
EXECUTING ON OUR VISION: A GLOBAL OPERATOR CONTROLLING THE ENTIRE VALUE CHAIN CANADA • WAGNERS and Highland Grow are popular adult-use brands in their categories • Highland ranked #1 in Ontario last 60 days • WAGNERS ranked #6 in Ontario last 60 days ISRAEL • Supply premium indoor cannabis domestica
Slide 8: The IMC Ecosystem
THE IMC ECOSYSTEM: We capitalize on our Israeli and Canadian expertise to drive sales and market trends SUPPLY FLOW: A SYNERGISTIC GLOBAL • Premium indoor supply from Canada flows to Israel and to Germany SUPPLY CHAIN • Future export of product channeled from Israel to Germany PAN-EUROPEAN DISTRIBUT
Slide 9: A Diverse Portfolio of Premium Brands
A DIVERSE PORTFOLIO OF PREMIUM BRANDS OF CHOICE DIVERSIFIED ‘HOUSE OF BRANDS’ WITH INCREASED DISTRIBUTION AND ABILITY TO CAPTURE A LARGER SHARE OF THE PREMIUM AND SUPER PREMIUM MARKET
Slide 10: Growth Engines
GROWTH Canada ENGINES • Increasing focus on premium cannabis, with category growth exceeding overall market in 2021 • Reaching full capacity of 7,000kgs by Q2 2022 • Launch of 5 new dried flower SKUs in Q1 and Q2 2022 • Launch of Diamond concentrates late in Q4 2021 • Entry into Quebec market in Q3
Slide 11: Healthy Financial Position to Execute Vision
HEALTHY FINANCIAL POSITION TO EXECUTE VISION 1. 2. 3. EQUITY CAPITAL SUMMARY M&A OPPORTUNITIES STRONG FINANCIAL POSITION - Currently trades as IMCC on the CSE - Current platform ripe for strategic, - Rapidly Q over Q revenue growth, both and NASDAQ opportunistic and accretive acquisitions organic an
Slide 12: Accelerating Quarterly Sales
ACCELERATING QUARTERLY SALES Quarterly Revenue Trends C$, thousands $16,000 $14,000 $12,000 $10,000 $8,000 $6,000 $4,000 $2,000 $0 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 12
Slide 13: Operations in Israel
OPERATIONS IN ISRAEL
Slide 14: Rapidly Growing Israeli Market
RAPIDLY GROWING • Exclusive commercial agreement with Focus ISRAELI MARKET Farms capable of producing 2,000 kgs per year of premium cannabis MEDICAL MARKET - PER CAPITA CONSUMPTION HIGHEST IN THE WORLD. SIGNIFICANT REGULATORY REFORM EXPECTED • Launch of popular WAGNERS brand in Israel in OVER THE NE
Slide 15: Distribution & Retail
DISTRIBUTION & April 2021 July 2021 August 2021 November 2021 RETAIL Panaxia to the Home Pharm Yarok, Rosen High Way Vironna Pharm Oranim Pharmacy Trade Center IMC ACHIEVES RETAIL AND E-COMMERCE LEADERSHIP THROUGH ACQUISITIONS WITH $20M IN COMBINED REVENUE RUN RATE • E-commerce dominance • Increased
Slide 16: Operations in Canada
OPERATIONS IN CANADA
Slide 17: Focused on Premium and Ultra-Premium
FOCUSED ON PREMIUM AND • Acquired Trichome Financial and MYM ULTRA-PREMIUM Nutraceuticals in 2021 • 7,000 kgs of premium, indoor capacity BRANDS, CULTIVATION CAPACITY, EXPORT TO ISRAEL AND GERMANY • Rapidly growing market share in premium and ultra-premium segments • Cultivation hub for export to Is
Slide 18: Operations in Europe
OPERATIONS IN EUROPE
Slide 19: Positioned for Market Leadership
POSITIONED Adjupharm acquired in 2020, establishing German distribution platform FOR MARKET LEADERSHIP Established infrastructure, licenses, supply and distribution Launch of popular WAGNERS brand in Germany in 2022 and importation of premium flower from Canada - Based MOH data including 3.8% monthl
Slide 20: Team
TEAM
Slide 21: IMC Board
IMC BOARD Oren Shuster Chief Executive Marc Lustig Brian Schinderle Haleli Barath Vivian Bercovici Officer & Director Executive Chairman Director Director Director Visionary, entrepreneurial and creative Cannabis capital markets expert, founder, Founder and Managing Partner of Solidum Co-founder and
Slide 22: IMC Leadership Team
IMC LEADERSHIP TEAM Oren Shuster Shai Shemesh, CPA Richard Balla Chief Executive Officer & Director Chief Financial Officer CEO & Director Adjupharm GMBH Visionary, entrepreneurial and creative leader with over 20 years Experienced CFO with nearly 15 years of business experience in Richard Balla, Ge
Slide 23: IMC Leadership Team
IMC LEADERSHIP TEAM Michael Ruscetta Yael Harrosh Howard Steinberg Co-Head North America General Counsel & Business Manager Co-Head North America Joined Trichome Financial in 2018 as Chief Executive Officer. Experienced lawyer with extensive expertise in corporate law as Joined Trichome Financial bo
Slide 24: Appendix
APPENDIX
Slide 25: IMC - Company Milestones
IMC - COMPANY MILESTONES Focus Medical begins IMC Holdings completes the acquisition - Focus Medical signs three-year sales IMC raised US$ 44.3 M operations in Israel of Adjupharm – EUGMP production and agreements in Israel for total of $193.5 million Acquires Panaxia to the home retail distribution
Slide 26: Thank You!
THANK YOU! NOVEMBER 2021